Discussion in 'Stocks' started by stonedinvestor, Jan 30, 2007.

  1. RPRX Repros Therapeutics Inc (NASDAQ GM) 14.21 +1.13 ( +8.64%)

    Check out the 10 day action on this since they announced a secondary. Unbelievable. Their lead candidate must be very good.. Anybody heard of this one before?
  2. blast19


    Nope...options are fairly cheap...interesting straddle perhaps. Could get into one for $1.50 for February.
  3. Well we've got a pullback to $12.11. and we have this today...
    CIBC initiates Repros Therapeutics (RPRX) with a Sector Outperformer and a $19 target saying in recent interim analyses of a phase II fibroids study and a ph.I/II endometriosis study, Proellex produced clear symptomatic improvements in both conditions. The firm believes there is a good probability of positive final results from these studies, driving upside for RPRX in 2H07...

    Stoney is thinking about it.......